CA2004764A1 - Proteines ancrod, leur preparation et leur utilisation - Google Patents

Proteines ancrod, leur preparation et leur utilisation

Info

Publication number
CA2004764A1
CA2004764A1 CA2004764A CA2004764A CA2004764A1 CA 2004764 A1 CA2004764 A1 CA 2004764A1 CA 2004764 A CA2004764 A CA 2004764A CA 2004764 A CA2004764 A CA 2004764A CA 2004764 A1 CA2004764 A1 CA 2004764A1
Authority
CA
Canada
Prior art keywords
pct
date
preparation
ancrod
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2004764A
Other languages
English (en)
Other versions
CA2004764C (fr
Inventor
Alfred Bach
Wolfgang Koerwer
Karl-Hermann Strube
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of CA2004764A1 publication Critical patent/CA2004764A1/fr
Application granted granted Critical
Publication of CA2004764C publication Critical patent/CA2004764C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6418—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals from snakes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002004764A 1988-12-10 1989-12-06 Proteines ancrod, leur preparation et leur utilisation Expired - Lifetime CA2004764C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3841736.7 1988-12-10
DE3841736A DE3841736A1 (de) 1988-12-10 1988-12-10 Ancrod-proteine, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
CA2004764A1 true CA2004764A1 (fr) 1990-06-10
CA2004764C CA2004764C (fr) 1999-07-06

Family

ID=6368940

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002004764A Expired - Lifetime CA2004764C (fr) 1988-12-10 1989-12-06 Proteines ancrod, leur preparation et leur utilisation

Country Status (11)

Country Link
US (1) US6015685A (fr)
EP (1) EP0447468B1 (fr)
JP (1) JP2783296B2 (fr)
AT (1) ATE123056T1 (fr)
AU (1) AU637589B2 (fr)
BR (1) BR1100940A (fr)
CA (1) CA2004764C (fr)
DE (2) DE3841736A1 (fr)
ES (1) ES2033212A6 (fr)
HU (1) HU211658A9 (fr)
WO (1) WO1990006362A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365155B1 (en) 1997-07-10 2002-04-02 Abbott Laboratories Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4023699A1 (de) * 1990-07-26 1992-01-30 Basf Ag Neue proteine, ihre herstellung und verwendung
US5759541A (en) * 1990-07-26 1998-06-02 Basf Aktiengesellschaft Recombinant fibrinogenases, the preparation and use thereof
US20030219431A1 (en) * 2002-05-24 2003-11-27 Empire Pharmaceuticals, Inc. Treatment of neuronal and neurological damage associated with spinal cord injury
CN108559740B (zh) * 2018-05-12 2021-05-18 吉林天衡康泰生物技术有限公司 重组安克洛酶及工业规模制备方法和治疗急性脑梗的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879369A (en) * 1972-05-12 1975-04-22 Abbott Lab Anti-coagulant isolation from malayan pit viper using affinity chromatography
DE2615844A1 (de) * 1976-04-10 1977-10-20 Knoll Ag Fibrinogen spaltendes enzymsystem
ZA889415B (en) * 1987-12-18 1989-09-27 Chiron Corp Compositions and method for recombinant production of crotalidus venum fibrolase
CA2015127A1 (fr) * 1989-04-26 1990-10-26 John G. Gray, Jr. Sequences d'adn encodant des polypeptides du genre ancrod et composes contenant le produit d'expression
DE4023699A1 (de) * 1990-07-26 1992-01-30 Basf Ag Neue proteine, ihre herstellung und verwendung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365155B1 (en) 1997-07-10 2002-04-02 Abbott Laboratories Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same

Also Published As

Publication number Publication date
EP0447468B1 (fr) 1995-05-24
DE3841736A1 (de) 1990-07-05
DE58909261D1 (de) 1995-06-29
CA2004764C (fr) 1999-07-06
JP2783296B2 (ja) 1998-08-06
AU4664489A (en) 1990-06-26
JPH04502252A (ja) 1992-04-23
ATE123056T1 (de) 1995-06-15
EP0447468A1 (fr) 1991-09-25
HU211658A9 (en) 1995-12-28
WO1990006362A1 (fr) 1990-06-14
AU637589B2 (en) 1993-06-03
BR1100940A (pt) 2000-08-01
US6015685A (en) 2000-01-18
ES2033212A6 (es) 1994-05-01

Similar Documents

Publication Publication Date Title
HK102192A (en) Human tumor necrosis factor and dna therefor
EP2145897A3 (fr) Procédés thérapeutiques et compositions basées sur des protéines serrate et acides nucléiques
WO1989009787A3 (fr) Dispositifs osteogeniques
WO1995025749A3 (fr) Peptides coupe-faim
CA2025900A1 (fr) Derive d'un activateur du plasminogene de type tissulaire
GB2302329B (en) Yeast strains
WO2000034474A3 (fr) Zvegf3 homologue du facteur de croissance
AU2308992A (en) Cysteine depleted il-6 muteins
EP0161007A3 (fr) Analogues de l'hexapeptide rétro-inverso C-terminal de la substance P
NO991995L (no) Nukleinsyre- og aminosyresekvenser relatert til Heliobacter pylori og vaksinesammensetninger derav
WO1988006625A3 (fr) Facteur de necrose tumorale humaine appauvri en arginine
CA2004764A1 (fr) Proteines ancrod, leur preparation et leur utilisation
AU590861B2 (en) New human lymphotoxin (TNF-beta) polypeptides their prepartion and use
CA2083286A1 (fr) Fibrinogenogenases recombinants, leur preparation et leur utilisation
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
CA2163805A1 (fr) Nouveau facteur d'activation des leucocytes
EP0267795A3 (fr) Mutéines de l'interleukine-2 de la souris
CA2247998A1 (fr) Fragments de recepteur du complement de type 1 et leurs utilisations
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
AU8830091A (en) Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry